Shanghai Chest Hospital is the first hospital in China specializing in cardiovascular systems, lung, esophagus, trachea and mediastinum.

There are 580 beds in Shanghai Chest hospital affiliated to Shanghai jiao tong university.

During the past decade, Shanghai Chest hospital affiliated to Shanghai jiao tong university conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shanghai Chest hospital affiliated to Shanghai jiao tong university" #1 sponsor was "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 2 trials, followed by "Shanghai Chest Hospital" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "CARsgen Therapeutics Co., Ltd." with 1 trials sponsored and "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shanghai Chest hospital affiliated to Shanghai jiao tong university" #1 collaborator was "Shanghai Zhongshan Hospital" with 2 trials as a collaborator, "CSPC ZhongQi Pharmaceutical Technology Co., Ltd." with 1 trials as a collaborator, "Changhai Hospital" with 1 trials as a collaborator, "Fujian Medical University Union Hospital" with 1 trials as a collaborator and "GeneCast Biotechnology Co., Ltd." with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Shanghai Chest hospital affiliated to Shanghai jiao tong university" are "Coronary Artery Disease" (2 trials), "Esophageal Cancer" (2 trials), "ALK Rearrangement Non-small Cell Lung Cancer" (1 trials), "Advanced Cancer" (1 trials) and "Advanced Malignant Tumor" (1 trials). Many other conditions were trialed in "Shanghai Chest hospital affiliated to Shanghai jiao tong university" in a lesser frequency.

Most popular intervention types in "Shanghai Chest hospital affiliated to Shanghai jiao tong university" are "Drug" (10 trials), "Procedure" (2 trials), "Combination Product" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "TQ-B3101" (2 trials), "esophagectomy" (2 trials), "Almonertinib" (1 trials), "Amlodipine, losartan potassium and hydrochlorothiazide" (1 trials) and "BAY2927088_formulation A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shanghai Chest hospital affiliated to Shanghai jiao tong university" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Shanghai Chest hospital affiliated to Shanghai jiao tong university". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Shanghai Chest hospital affiliated to Shanghai jiao tong university, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shanghai Chest hospital affiliated to Shanghai jiao tong university, 5 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".